Intravenous Ancrod for the Treatment of Acute Ischemic Stroke Within 6 Hours After Onset of Symptoms


Phase 3 Results N/A

Summary of Purpose

Treatment of acute stroke is still difficult and the only specific drug approved (rtPA) can only be administered if treatment starts within 3 hours after onset of symptoms. This results in a still too small number of patients treated with rtPA ( < 15% in best clinical care institutions ). Ancrod is a differently acting biological drug which has been used for a long time but not for acute stroke treatment. STAT...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 June 2006.

Unavailable 20 Jun 2006 Unavailable Unavailable 1 Jan 2002 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


Not available